GABRIELLE CURTIS: Open Payments
NPI 1326076993 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 29 payments from 14 companies in 2025. Trend: 2023 $29 · 2024 $96 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 2 | $78 |
| PROTEGA PHARMACEUTIALS INC | 4 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| ViiV Healthcare Company | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Alkermes, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
Products named: Senza, ROXYBOND, INGREZZA, APRETUDE, ARISTADA, XTAMPZA, REXULTI, CAPLYTA.
Industry payments across MO — which companies pay providers there.
